Brussels, 27/04/2004 (Agence Europe) - As we previously announced the Commission has authorised, under the proposed acquisition of Aventis SA by Sanofi-Synthélabo subject to a number of conditions. The transaction, which will create the third largest pharmaceutical company in the world after Pfitzer in the USA and Glaxosmithkline, Britain. The new company Sanofi Aventis will attain profits in the range of EUR bn with a workforce of 103,000. During its examination, the Commission raised...